On Thursday, GSK plc (NYSE:GSK) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

The increase has been faster in women since 2000. The rising incidence of multiple myeloma (MM), particularly in relapsed and ...

Students at the East Rock Community Magnet School honored one of their former teachers Thursday by unveiling a cluster of ...

She was born December 16, 1962, in Cape Girardeau to Robert and Nancy Kent Littleton. She and Stephen Puchbauer were married ...

Sanofi said that Sarclisa, its treatment for plasma cell cancer, was recommended for EU approval by the European Medicines Agency. The agency's Committee for Medicinal Products for Human Use ...

Join the 29th annual "Sounds of the Season" concert Dec. 1 at Discover Life Church, supporting cancer patients through music.

BeiGene (NASDAQ:BGNE – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday. Several ...

Emily John, from the charity Anthony Nolan, calls for fairer access to a treatment that uses a patient’s own immune system to ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...